)
China Traditional Chinese Medicine (570) investor relations material
China Traditional Chinese Medicine H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue for H1 2026 was RMB5,438.5 million, down 27.1% year-over-year, mainly due to policy-driven declines and weaker demand in concentrated TCM granules.
Gross profit fell 29.0% to RMB2,580.8 million, with gross margin decreasing by 1.2 percentage points to 47.5%.
Net loss widened to RMB834.7 million from RMB141.8 million in H1 2025, driven by lower sales, goodwill impairment, and increased asset impairments; net profit margin at -15.3%.
Basic and diluted loss per share was RMB-15.42 cents, compared to RMB-2.14 cents in the prior year period.
Financial highlights
Revenue by segment: Concentrated TCM granules RMB1,932.9m (-35.4%), TCM finished drugs RMB1,663.0m (-28.0%), TCM decoction pieces RMB1,559.6m (-2.3%), Chinese medicinal herbs/integration RMB189.6m (-57.5%), TCM great health RMB93.4m (-23.5%).
Gross profit margin: 47.5% (down 1.2pp); net profit margin: -15.3% (down 13.4pp).
Goodwill impairment of RMB645.2m recognized, mainly in the concentrated TCM granules business.
Selling and distribution expenses decreased 26.1% to RMB1,890.1m; administrative expenses rose 10.3% to RMB552.1m.
R&D expenses dropped 26.8% to RMB187.5m; finance costs decreased to RMB33.9m.
Outlook and guidance
The company plans to deepen reform, focus on quality improvement, and drive innovation-led growth in H2 2026.
Strategic priorities include expanding market share in TCM decoction pieces, adapting to policy reforms in granules, and strengthening academic promotion for finished drugs.
Emphasis on digital transformation, operational efficiency, and compliance to support long-term stability.
- Revenue declined 10.7% and net loss reached RMB458.1 million amid restructuring and impairments.570
H2 2025 - Revenue fell 11% and a net loss of RMB141.8 million was recorded amid market headwinds.570
H1 2025 - Revenue and profit dropped sharply, but TCM finished drugs and decoction pieces grew.570
H1 2024 - Net profit dropped 98.5% on lower revenue and asset impairments, despite resilient core segments.570
H2 2024
Next China Traditional Chinese Medicine earnings date
Next China Traditional Chinese Medicine earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)